Answers are grounded in this paper and cite their sources.
Early salvage radiotherapy is indicated for patients with biochemical recurrence after radical prostatectomy. However, for various reasons, certain patients do not benefit from this treatment (OBS) or only at a late stage (LSR). There are few studies on this subject and none on a "high-risk" population, such as patients of African descent. Our objective was to estimate the metastasis-free (MFS) and overall survival (OS) of patients who did not receive salvage radiotherapy, and to identify risk factors of disease progression.
No takes yet. Share an insight, caveat, or question.
Barrière et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: